Welcome to the ePoster Viewing Panel of AICOG 2025

Introduction Placental abruption is serious cause of maternal and fetal morbidity and mortality. The risk of recurrence after a first episode is between 4?12%, and increases to 25% after two episodes. Case history: 27 years, Mrs XYZ G3P1L1A1, a known chronic hypertensive presented to our casualty at 35+2 weeks with complaints of decreased perception of fetal movements and pain abdomen for 24 hours. Her first pregnancy was uneventful. Second pregnancy was complicated by early onset severe pre-eclampsia with REDF in fetus detected at 23+2 weeks warranting termination of pregnancy. She expelled a 490 gm fetus with 100 gm retroplacental clots and received blood transfusion. At admission she was hemodynamically stable. Uterus was tense tender and term size and fetal heart sound was not audible. Ultrasonography was suggestive of intrauterine death with retroplacental clots indicative of abruptio placenta. Patient was started on Magnesium sulphate. Artificial rupture of membranes revealed blood stained liquor. In view of deranged coagulation profile and moderate anemia she received blood and FFP transfusion. Patient progressed and expelled a still born baby. 110 grams of retroplacental clots were noted. Mild uterine atonicity was medically managed. Patient was discharged in stable condition. Conclusion In cases of recurrent placental abruption it is important to rule out other underlying causes including an autoimmune etiology. Daily Aspirin initiated at < 16 weeks gestation may decrease risk of placental abruption secondary to preeclampsia. Obstetricians should have a high index of clinical suspicion in patients with past history of placental abruption. In subsequent pregnancy, close monitoring should be done for clinical signs. Modifiable risk factors such as cigarette smoking and drug use are ideally addressed preconceptionally.